GAMMA Investing’s AngioDynamics ANGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$28.4K Buy
2,184
+325
+17% +$3.7K ﹤0.01% 2653
2026
Q1
$21.1K Buy
1,859
+165
+10% +$1.79K ﹤0.01% 2683
2025
Q4
$21.8K Buy
1,694
+329
+24% +$4.06K ﹤0.01% 2562
2025
Q3
$15.2K Sell
1,365
-335
-20% -$3.23K ﹤0.01% 2663
2025
Q2
$16.9K Buy
1,700
+220
+15% +$2.15K ﹤0.01% 2545
2025
Q1
$13.9K Buy
1,480
+474
+47% +$4.98K ﹤0.01% 2585
2024
Q4
$9.21K Buy
1,006
+408
+68% +$3K ﹤0.01% 2658
2024
Q3
$4.65K Buy
598
+216
+57% +$1.56K ﹤0.01% 2772
2024
Q2
$2.31K Buy
382
+258
+208% +$1.59K ﹤0.01% 2841
2024
Q1
$728 Sell
124
-656
-84% -$3.9K ﹤0.01% 3017
2023
Q4
$4.6K Buy
+780
New +$5.41K ﹤0.01% 2277

Other funds holding ANGO

GAMMA Investing's ANGO Position: Q2 2026 in Review

GAMMA Investing increased its AngioDynamics (ANGO) stake by 17% in Q2 2026, buying an estimated $3.7K and bringing the position to 2,184 shares worth $28.4K. The position accounts for ﹤0.01% of the portfolio, ranked #2653.

GAMMA Investing first reported a position in ANGO in Q4 2023 and has held it in 11 quarters since. 16 funds tracked by Wall St. Rank hold ANGO as of Q2 2026.

  • GAMMA Investing held 2,184 shares of AngioDynamics worth $28.4K as of Q2 2026.
  • GAMMA Investing bought 325 AngioDynamics shares in Q2 2026, an estimated $3.7K.
  • AngioDynamics made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #2653 holding.
  • GAMMA Investing first reported a position in AngioDynamics in Q4 2023 and has held it in 11 quarters since.
  • 16 funds tracked by Wall St. Rank held AngioDynamics as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.